English
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
Gene Therapy Improves Muscle Function for Children With Spinal Muscular Atrophy
Children with spinal muscular atrophy (SMA) carry specific gene defects which cause progressive muscle wasting and weakness. Left untreated, the condition usually results in early death. Approval was recently granted for a gene replacement therapy that enables the maintenance of muscle function. However, due to the treatment’s relative novelty, data on safety and efficacy remain limited.
A team from Charité – Universitätsmedizin Berlin recently conducted the first multicenter clinical study to evaluate data on the side effects associated with this new gene replacement therapy. Their study showed that treatment resulted in significant improvement in muscle function, particularly in children under two years of age. The researchers’ findings have been published in The Lancet Child & Adolescent Health.
BookmarkRelated Content
-
Megan A. Waldrop, MDMegan Waldrop, MD, is a Pediatric Neurol...
-
Kathrin C. Meyer, PhDKathrin C. Meyer, PhD, studied Cellular ...
-
The Pediatric SMA Clinic – Columbia UniversityThe Pediatric SMA Clinic is committed to...
-
Alex Fay, PhDDr. Alex Fay is a pediatric neurologist ...
-
Baby First at UNC to Receive Gene Therapy for SMA, Thanks to Early Check Newborn ScreeningIt was a pregnancy that went relatively ...
-
Emma Ciafaloni, MDDr. Ciafaloni is a Professor of Neurolog...
-
Will Parental Vaccine Hesitancy Retard the Embrace of Life-Saving Newborn Genetic Screening and Emerging Gene Therap...In these days of the never-ending pandem...
Powered by
In partnership with
